Necrotic Enteritis in Poultry

Etiology, Pathogenesis, Predisposing Factors, Clinical Signs, Diagnosis, Treatment, and Control

A Veterinary Reference Guide for Poultry Producers and Flock Owners

Necrotic enteritis (NE) is one of the most economically devastating enteric diseases in the global poultry industry. Caused by toxin-producing strains of Clostridium perfringens, it strikes primarily young broilers and can kill birds so rapidly that the first indication of a problem is simply finding dead animals. The global economic losses attributable to necrotic enteritis are estimated at up to six billion U.S. dollars per year (Pathogens, MDPI, 2022), driven not only by direct mortality but by the significant subclinical form of the disease — a chronic, low-grade infection that quietly erodes weight gain, worsens feed conversion ratios, and reduces flock efficiency without producing obvious clinical signs.

Necrotic enteritis has experienced a dramatic resurgence in recent decades. The disease was well controlled throughout much of the late 20th century through the routine use of in-feed antimicrobial growth promoters (AGPs). When AGPs were banned in the European Union in 2006 and subjected to increasing regulatory pressure worldwide, NE re-emerged as a primary poultry health challenge. Understanding this disease, its predisposing factors, and the growing toolkit of non-antibiotic prevention strategies is now essential knowledge for any poultry producer or flock manager.

Quick Reference Summary

Category	Detail	Notes
Causative Agent	Clostridium perfringens Types A and G (formerly Type C)	Gram-positive, anaerobic, endospore-forming rod
Key Virulence Factor	NetB toxin (necrotic enteritis B-like toxin)	Plasmid-encoded; pore-forming; primary driver of lesions
Secondary Toxins	Alpha-toxin (CPA), TpeL toxin	Alpha-toxin contributes; TpeL may enhance virulence
Primary Hosts	Broiler chickens (2–5 weeks)	Also turkeys (7–12 weeks), layer pullets
Transmission	Environmental; fecal-oral; ubiquitous organism	C. perfringens is normal gut flora; disease requires trigger
Key Predisposing Factors	Coccidiosis (Eimeria), high-protein diet, feed changes	Also: mycotoxins, immunosuppression, litter management
Mortality Rate	Up to 50% in clinical form	Subclinical form causes production losses without obvious death
Key Clinical Signs	Sudden death, severe depression, dark diarrhea	Disease progression may be hours to 1–2 days
Key Lesions	Brown-black necrotic mucosa, gas-distended small intestine	Primarily affects jejunum and ileum
Diagnosis	Gross lesions; Gram stain of intestinal contents; culture; PCR for netB	Definitive: netB-positive C. perfringens isolation
Treatment	Antimicrobials in water (penicillin, ampicillin, lincomycin)	Rapid intervention critical; death within 24 hrs common
Prevention	Coccidiosis control, diet management, probiotics, vaccines	AGP ban has driven adoption of multimodal prevention strategies
Zoonotic Risk	Low for NE-associated strains specifically	C. perfringens type A causes food poisoning in humans; separate issue
Reportable?	Not federally reportable in U.S.	Report significant flock losses per state guidelines

1. Historical Background and Economic Significance

Necrotic enteritis was first described as a distinct clinical entity in broiler chickens in the 1960s (Helmboldt and Bryant, 1971, as cited in multiple subsequent reviews). The disease was recognized early as an enteric disorder associated with high mortality and characteristic intestinal lesions, but its full pathogenic mechanism remained poorly understood for decades.

Through the 1970s, 1980s, and 1990s, NE was largely controlled in commercial poultry operations through the routine inclusion of AGPs in poultry feed. Antibiotics such as avoparcin, lincomycin, amoxicillin, tylosin, virginiamycin, and bacitracin were widely used both as growth promoters and for prophylactic control of C. perfringens overgrowth. This approach was highly effective, and NE was considered a manageable background risk during this period.

The European Union’s ban on AGPs in feed (EU Regulation No. 1831/2003, implemented in 2006) triggered an immediate and well-documented resurgence. A study cited in the comprehensive Poultry Science review (ScienceDirect, 2021) found that in Norway, 0% of flocks raised under conventional antibiotic programs had clinical NE, whereas 27% of drug-free flocks developed clinical NE and 49% developed subclinical NE. The PMC review by Frontiers in Microbiology (Casewell et al., 2003, as cited in Gut Pathogens) notes that the AGP ban was a major reason for the re-emergence of NE as a leading cause of economic loss. Similar trends have been documented globally as regulatory pressure on AGP use has intensified in the United States, Canada, Australia, and elsewhere.

The PMC Pathogens review (Kulkarni et al., 2022, North Carolina State University and University of Guelph) estimates global economic losses from NE at six billion U.S. dollars per year, encompassing direct mortality, subclinical production losses including reduced body weight, impaired feed conversion ratios, increased medication costs, and carcass condemnations at processing.

2. Etiology and Classification

The Organism

Necrotic enteritis is caused by Clostridium perfringens, a gram-positive, obligate anaerobic, endospore-forming rod-shaped bacterium. The Merck Veterinary Manual (reviewed/revised April 2023) describes C. perfringens as a nearly ubiquitous bacterium readily found in soil, dust, feces, feed, and used poultry litter, and also as a normal inhabitant of the intestines of healthy chickens and turkeys. The critical concept is that the presence of the organism does not cause disease — disease occurs only when specific predisposing conditions allow the organism to proliferate in large numbers and produce sufficient toxin to damage the intestinal mucosa.

perfringens has historically been classified into types A through G based on toxin production. The Gut Pathogens review (Experimental Induction Study, Springer Nature, 2021) describes the current toxinotyping scheme under which C. perfringens type G — defined by possession of the netB gene encoding the NetB toxin — is now recognized as the primary causative type in poultry necrotic enteritis. Type A (producing alpha-toxin) and the older designation of type C (producing both alpha- and beta-toxin) also contribute, though their independent roles are now understood to be secondary to netB-positive strains.

The NetB Toxin: Primary Virulence Factor

The discovery of the NetB toxin in 2008 fundamentally changed the scientific understanding of NE pathogenesis. The PMC review (Role of C. perfringens Necrotic Enteritis B-like Toxin in Disease Pathogenesis, PMC8780507, 2022) describes NetB as a plasmid-encoded, pore-forming heptameric protein that is the primary virulence factor in NE. Unlike the earlier assumption that alpha-toxin was the dominant driver of intestinal lesions, research since 2008 has consistently demonstrated that NetB-positive strains are the critical determinant of NE virulence in chickens.

The Veterinary Research review (Successful Experimental Induction of Necrotic Enteritis, BioMed Central, 2012) characterizes NE as caused by avian-specific, NetB-producing strains of C. perfringens that also carry other virulence-associated genes in common. The plasmid location of the netB gene is significant — it allows horizontal gene transfer between C. perfringens strains, which has implications for the spread of virulent genotypes within and between flocks.

The PMC perfrin study (Ghent University / University of Guelph, PMC3992141, 2014) further describes how netB-positive C. perfringens strains isolated from NE outbreaks are more capable of secreting factors that inhibit growth of other C. perfringens strains, allowing them to selectively dominate the intestinal environment and concentrate their toxin-producing population — a mechanism that facilitates the rapid escalation from normal gut colonization to pathological overgrowth.

Secondary Toxins

Alpha-toxin (CPA), a chromosomally encoded phospholipase C enzyme, was originally believed to be the primary virulence factor in NE but is now understood to play a supporting rather than primary role. The PMC Pathogens review (2022) acknowledges that alpha-toxin contributes to NE but is insufficient alone to produce the disease. The TpeL toxin (large clostridial toxin) has been identified in some virulent NE strains and may enhance pathogenicity, though its role is described as circumstantial in the Gut Pathogens review (2021) and not yet definitively established.

3. Epidemiology and Predisposing Factors

Age and Species Susceptibility

The Merck Veterinary Manual states that NE affects primarily broiler chickens 2–5 weeks of age and turkeys 7–12 weeks old raised on litter, though commercial layer pullets raised in cages can also be affected. The PMC Frontiers in Microbiology review (Alternatives to Antibiotics, PMC4664614) notes that young animals with immature immune systems and no established commensal flora are primarily at risk. The Pennsylvania State University Extension (Avian Necrotic Enteritis) confirms that many factors must co-occur for NE to develop, with dietary factors and Eimeria co-infection being the most consistent requirements.

Coccidiosis as the Primary Predisposing Factor

Eimeria infection (coccidiosis) is the single most important predisposing factor for NE. The Merck Veterinary Manual states that early mortality in NE outbreaks is often related to concurrent coccidiosis, with Eimeria cycling in affected flocks. The mechanism is well characterized: Eimeria spp. damage the intestinal epithelium, disrupting the mucosal barrier, releasing mucosal proteins that serve as nutritional substrates for C. perfringens, and altering the intestinal microenvironment in ways that favor C. perfringens overgrowth.

The PMC Role of NetB Toxin review (2022) describes coccidiosis as a major contributing factor to NE, noting that the host-pathogen interaction in NE pathogenesis is complex and that Eimeria-damaged mucosa creates the permissive environment for C. perfringens toxin production. Eimeria maxima and Eimeria necatrix are the species most consistently associated with NE predisposition, as they produce the most extensive small intestinal damage. The Gut Pathogens experimental study (2021) used Eimeria-challenged birds as the primary predisposing model for consistent NE induction.

Dietary Predisposing Factors

Certain dietary components are well-established NE predisposing factors, independent of coccidial co-infection. The Merck Veterinary Manual identifies Eimeria infection and certain dietary substrates as the main causes of the intestinal microflora disruption that creates a permissive environment for C. perfringens overgrowth. Key dietary factors include:

High animal-protein diets (fish meal, meat meal): High levels of undigested protein in the intestinal lumen provide fermentable substrates for C. perfringens. Fish meal-based diets are particularly strongly associated with NE outbreaks. The Gut Pathogens study (2021) used maize plus fish meal diets to increase NE lesion severity in experimental animals.
Wheat and rye-based diets: These grains are high in non-starch polysaccharides (NSPs) that increase intestinal viscosity, slow digesta passage, and alter gut microbiota composition in ways that favor C. perfringens proliferation.
Sudden diet changes: Abrupt transitions between feed formulations disrupt the established intestinal microbiota balance and can trigger C. perfringens overgrowth.
Mycotoxin contamination of feed: Mycotoxins suppress intestinal immunity and damage the mucosal barrier, creating conditions favorable for C. perfringens overgrowth.

Other Predisposing Factors

Immunosuppressive diseases: Infectious bursal disease (IBD/Gumboro), Marek’s disease, and chicken anemia virus all suppress immune competence and increase NE susceptibility
Overcrowding and litter management issues: High bird density, wet litter, and poor ventilation create environmental conditions favorable to C. perfringens spore survival and fecal-oral transmission
Concurrent intestinal disease: Mycotoxicosis, rotavirus, and astrovirus infections that damage the intestinal epithelium share the same predisposing mechanism as Eimeria
Cannibalism: The Poultry Site reference notes that failure to collect dead birds promptly leads to cannibalism, exposing live birds to large numbers of C. perfringens and accelerating disease spread

4. Pathogenesis

Under normal circumstances, C. perfringens is a low-level commensal in the chicken intestine, kept in check by the indigenous gut microbiota, mucosal immune defenses, and the competitive microbial environment. NE develops when predisposing conditions disrupt this balance, allowing C. perfringens — specifically netB-positive strains — to proliferate rapidly to pathological numbers.

The PMC Pathogens review (2022) describes C. perfringens as a fast-growing bacterium with a generation time of 8–12 minutes when cultured at 43°C in optimal media. Under permissive intestinal conditions, this rapid growth rate allows the organism to overwhelm competing microbiota and colonize the small intestinal mucosa in massive numbers within hours.

Once established in sufficient numbers, netB-positive strains secrete the NetB toxin, which inserts into the intestinal epithelial cell membranes and forms heptameric pores — channels that disrupt cellular osmotic balance and trigger cell death. The PMC review (PMC8780507) describes NetB as a plasmid-encoded pore-forming heptameric protein that is the primary virulence factor in NE. The result is rapid, extensive necrosis of the intestinal epithelium, producing the characteristic patches and sheets of necrotic tissue that define the gross pathology of the disease.

Alpha-toxin (phospholipase C) simultaneously degrades cell membranes, contributing to mucosal destruction and the inflammatory cascade. The combined effect of toxin production, mucosal necrosis, and secondary inflammatory response produces a severe enterotoxemia — a systemic toxic state driven by absorbed bacterial toxins — that can kill birds within hours of clinical onset.

In the subclinical form, the process is less severe: C. perfringens proliferates and produces sublethal levels of toxin that cause microscopic intestinal damage and impair nutrient absorption without producing overt clinical disease or visible gross lesions. This form is described by the Poultry Science comprehensive review (ScienceDirect, 2021) as clostridiosis, and it is responsible for the production losses — reduced weight gain, impaired feed conversion, and decreased European Broiler Index — that account for the majority of NE’s global economic impact.

5. Clinical Signs

Per-Acute and Clinical Form

The Merck Veterinary Manual describes NE as an acute enterotoxemia in which clinical signs are usually very short-lived, and often the only sign is a severe depression followed quickly by a sudden increase in flock mortality. The disease progression can be extraordinarily rapid — the PMC Frontiers review (PMC4664614) notes that the rapid death within 24 hours of chickens with NE often prevents treatment of the disease.

When clinical signs are observed before death, they include:

Severe, sudden-onset depression and lethargy
Ruffled feathers and reluctance to move
Loss of appetite, reduced water consumption
Dark brown to blackish, often bloody diarrhea with foul odor
Abdominal distension from gas-filled intestines
Hunched posture; birds may be found in lateral recumbency before death
Sudden spike in flock mortality — often the first unambiguous signal of an outbreak

Subclinical Form

The subclinical form, often called subclinical NE or clostridiosis, produces no obvious clinical signs. Affected flocks appear superficially healthy, but performance metrics deteriorate progressively. The Poultry Science review (ScienceDirect, 2021) identifies the following production indicators of subclinical NE:

Reduced body weight and impaired weight gain
Worsening feed conversion ratio (FCR) — birds consuming more feed per unit of body weight gained
Reduced European Broiler Index or European Production Efficiency Factor
Increased proportion of carcass condemnations at processing due to intestinal lesions discovered post-mortem

The subclinical form is considered by many in the poultry industry to be more economically important than the clinical form because it affects a larger proportion of the flock over a longer period, and its insidious nature makes it easy to miss without proactive monitoring.

6. Gross Pathology and Post-Mortem Lesions

Post-mortem examination is the most reliable field tool for confirming NE. The characteristic gross lesions are found primarily in the small intestine, particularly the jejunum and ileum. Penn State Extension (Avian Necrotic Enteritis) and the Merck Veterinary Manual both describe NE as characterized by patches of necrotic tissue on the intestinal epithelium.

Acute Lesions

The small intestine is ballooned, friable, and gas-distended, with a characteristic foul odor
The intestinal wall is thin and fragile, tearing easily on handling
The intestinal mucosa is covered by a brown-black or yellowish-green necrotic pseudomembrane that resembles a “Turkish towel” pattern — a description used in veterinary pathology references
The necrotic material may slough off, leaving a raw, ulcerated underlying mucosa
The liver may show pale, circular necrotic foci — a manifestation of the concurrent cholangiohepatitis that frequently accompanies severe NE outbreaks
Petechial hemorrhages may be present on the intestinal serosa

Subclinical Lesions

Subclinical NE lesions are subtle and may only be identified by careful post-mortem examination or histopathology. The intestinal mucosa may show focal areas of villus atrophy, epithelial erosion, and inflammatory cell infiltration without the gross necrosis of the clinical form. These lesions impair absorptive surface area and contribute to the production losses associated with subclinical disease.

Cholangiohepatitis

Cholangiohepatitis — inflammation of the bile ducts and liver — is a recognized complication and sometimes the primary lesion in NE-affected flocks. The Poultry Site reference cites Kaldhusdal and Lovland (2002) from the Elanco Global Enteritis Symposium as describing clostridial necrotic enteritis and cholangiohepatitis as a linked clinical presentation, with C. perfringens ascending the bile duct from the intestine to produce hepatic lesions that can cause chronic production losses even after the enteric component of the disease resolves.

7. Diagnosis

Presumptive Diagnosis

The Merck Veterinary Manual states that a presumptive diagnosis is based on clinical signs of diarrhea and depression combined with the characteristic gross lesions of the small intestine. The combination of sudden mortality in 2–5 week-old broilers, severe depression, and the grossly necrotic intestinal mucosa with its characteristic odor is highly suggestive. Penn State Extension confirms that many factors must co-occur for NE to develop, so the presence of concurrent coccidiosis or a high-protein diet history adds weight to the presumptive diagnosis.

Microscopic Confirmation

The Merck Veterinary Manual states that confirmation is based on gross lesions in the small intestine and microscopic observation of gram-positive rods in intestinal contents or mucosal smears. A Gram stain of intestinal content or a mucosal impression smear revealing large numbers of gram-positive, rod-shaped organisms in association with necrotic lesions is a rapid and practical confirmation tool available to veterinary practitioners.

Bacterial Culture

perfringens is isolated on blood agar under anaerobic conditions at 37°C, where it produces the characteristic double zone of hemolysis (the inner zone of complete hemolysis by theta-toxin and the outer zone of incomplete hemolysis by alpha-toxin) described by the Merck Veterinary Manual. Culture allows isolation of the organism but does not by itself confirm a virulent, NE-producing strain.

Molecular Diagnostics and netB PCR

Because the presence of C. perfringens alone is insufficient to diagnose NE — the organism is present in healthy birds — confirmation of virulent, netB-positive strains is the gold standard for definitive diagnosis. The Gut Pathogens review (2021) states that the critical bacterial factor for experimental NE induction is the use of virulent, netB-positive strains, and that experimental studies have consistently demonstrated a reliable NE induction model depends mainly on netB-positive C. perfringens. PCR assays targeting the netB gene are widely available at state and university veterinary diagnostic laboratories and provide rapid, specific confirmation.

The comprehensive Poultry Science review (ScienceDirect, 2021) identifies the full diagnostic approach as including case history, clinical signs, gross and histopathological lesions, pathogenic agent identification, serological testing, and molecular identification — with molecular confirmation of the netB gene now considered the definitive standard for research and clinical NE diagnosis.

8. Treatment

When NE is diagnosed or strongly suspected in a flock, rapid antimicrobial intervention is critical. The Merck Veterinary Manual states that treatment is by antimicrobial-medicated drinking water. Because many birds with acute NE are too ill to eat, water-administered antibiotics ensure better delivery to affected animals than in-feed medication during an active outbreak.

Antimicrobial Options

Antimicrobials with documented efficacy against C. perfringens in poultry include:

Penicillin and ampicillin: Among the most effective and widely used options. C. perfringens has historically shown low resistance to beta-lactam antibiotics. Water-soluble formulations allow rapid flock-wide treatment.
Lincomycin: Specifically labeled for C. perfringens in poultry in the United States. Highly effective and well absorbed from water.
Bacitracin: Used both therapeutically and historically as a preventive feed additive (AGP). Effective against gram-positive organisms including C. perfringens.
Tetracyclines: Broad-spectrum; used in some regions. Resistance rates are variable.
Tylosin: A macrolide antibiotic used in some therapeutic NE protocols.

The PMC Frontiers in Microbiology review (PMC4664614) cautions that the rapid death within 24 hours of birds with NE often prevents treatment of the disease — underscoring that identifying an outbreak early and initiating treatment immediately upon suspicion, before laboratory confirmation, is often necessary to limit losses.

Limitations of Treatment

Antimicrobial treatment of an active NE outbreak reduces mortality but does not address the underlying predisposing factors. If coccidiosis, diet composition, or litter management issues are not corrected simultaneously, outbreaks will recur after the treatment course ends. Treatment should always be accompanied by aggressive investigation and correction of predisposing conditions.

9. Prevention and Control

NE prevention requires a multimodal approach targeting the organism, its predisposing factors, and the intestinal environment. The withdrawal of AGPs globally has made prevention strategies the central focus of NE management research.

Coccidiosis Control

Because coccidiosis is the single most important predisposing factor for NE, effective Eimeria control is the cornerstone of NE prevention. The Merck Veterinary Manual and Penn State Extension both identify coccidiosis control as essential. Approaches include:

Coccidiostat-medicated feed (amprolium, ionophores such as monensin, narasin, or salinomycin) for non-vaccinated flocks
Coccidiosis vaccination for day-old chicks — increasingly used in antibiotic-free production systems, as it primes immunity without relying on medicated feed
Litter management: maintaining dry, friable litter reduces Eimeria oocyst sporulation and environmental load

Diet Management

Dietary modification to reduce the substrate available for C. perfringens proliferation is an important prevention strategy. The Poultry Science comprehensive review (ScienceDirect, 2021) highlights the importance of:

Reducing or eliminating fish meal and other high-protein animal byproducts from broiler diets during high-risk periods
Minimizing wheat and rye content, or using NSP-degrading enzyme supplementation (xylanases, glucanases) when these grains are included
Avoiding abrupt feed transitions; when diet changes are necessary, gradual transition over 3–5 days reduces microbiota disruption
Ensuring feed quality: monitoring for mycotoxin contamination, which predisposes to NE through mucosal damage

Probiotics

The PMC Pathogens review (Kulkarni et al., 2022, North Carolina State University / University of Guelph) provides a comprehensive review of probiotics as NE control alternatives. Probiotic mechanisms relevant to NE prevention include:

Competitive exclusion: beneficial bacteria (Lactobacillus, Enterococcus, Bacillus, Butyricicocus spp.) compete with C. perfringens for intestinal colonization sites and nutrients
Mucosal integrity enhancement: probiotics upregulate tight-junction protein expression, strengthening the epithelial barrier against toxin penetration
Immune modulation: probiotics downregulate expression of pro-inflammatory cytokines, reducing inflammatory damage
Short-chain fatty acid production: butyrate-producing bacteria improve enterocyte health and mucosal integrity

The Pathogens review concludes that probiotics offer a promising platform for NE control but that more investigation is needed to determine optimal strains, doses, and application methods for commercial settings.

Vaccines

The development of effective NE vaccines has been a major research priority since the AGP ban. The University of Arkansas study published in Microorganisms (PMC9228780, 2022) investigated C. perfringens sporulation proteins as vaccine candidates and demonstrated significant reduction in NE in vaccinated chickens. Commercially available vaccines based on NetB toxoid and alpha-toxoid formulations are available in some markets, providing active immunization against the primary virulence factors.

The PMC Role of NetB Toxin review (2022) notes that since the discovery of NetB toxin, its use as a vaccine antigen has been a primary research focus, and several experimental and commercial NetB-based vaccines have shown promise in reducing NE severity and mortality in challenge models.

Other Prevention Strategies

Organic acids: Short- and medium-chain fatty acids (caprylic, capric, lauric acids) have demonstrated antimicrobial activity against C. perfringens in vitro and in vivo. The BMC Infectious Diseases study (PMC9808942, 2023) showed that microencapsulated fatty acid combinations reduced NE-induced lesions in broilers.
Litter management: Frequent litter replacement or amendment, maintaining dry conditions, and avoiding overcrowding all reduce fecal C. perfringens load in the environment.
Prompt removal of dead birds: The Poultry Site reference emphasizes that failure to collect and dispose of dead birds promptly leads to cannibalism, exposing live birds to large numbers of C. perfringens and accelerating the spread of the disease.
Rodent and wild bird control: Rodents and wild birds can introduce C. perfringens and Eimeria oocysts into poultry houses, contributing to both predisposing coccidial burden and direct C. perfringens exposure.

10. Zoonotic Considerations

perfringens type A is one of the most common causes of food-borne illness in humans worldwide, producing a gastroenteritis syndrome associated with consumption of contaminated meat, poultry, and other protein-containing foods. However, this human disease is caused primarily by the enterotoxin (CPE) produced by type A strains, a toxin that is distinct from the NetB toxin responsible for poultry NE. The enterotoxin-producing strains are widespread in the environment and food supply and are not uniquely associated with clinical NE in flocks.

For flock owners and farm workers, the risk of NE-associated C. perfringens causing direct human illness through contact with affected birds is considered low. Standard food safety and personal hygiene practices — handwashing, proper poultry carcass handling and cooking temperatures, and avoiding cross-contamination in food preparation — are the appropriate risk mitigation measures.

11. What This Means for Backyard and Small Flock Owners

While NE is most often discussed in the context of commercial broiler production, it can and does occur in backyard flocks, particularly in mixed-species situations, flocks with active coccidiosis, or flocks fed high-protein table scraps or unconventional diets.

Key Points for Flock Owners

Sudden mortality in 2–5 week old chicks or young birds with no premonitory signs, particularly following a period of loose or dark bloody stools, should prompt immediate post-mortem examination and veterinary consultation.
Coccidiosis control is your most important NE prevention tool. Keep litter dry, manage stocking density, and use appropriate coccidiosis prevention (medicated feed or vaccination) in all young flocks.
Feed quality matters. Avoid high-protein scraps, fish-based supplements, and sudden diet changes. Moldy or mycotoxin-contaminated feed is a significant NE predisposing factor.
Collect dead birds promptly. Cannibalism of infected carcasses is an efficient route for C. perfringens spread within a flock. Remove and properly dispose of mortality daily.
Treatment must be immediate. NE can kill birds within 24 hours of clinical onset. If NE is suspected, contact a veterinarian promptly and begin antimicrobial treatment in the water supply without waiting for laboratory confirmation.
Subclinical NE is invisible but costly. If your flock’s growth rate seems slower than expected or feed consumption seems disproportionate to weight gain, consider NE as a possible cause and consult a veterinarian for intestinal health assessment.